HSPB3 and myopathy: The p.Arg116Pro mutation which we found in this gene has recently been described in a patient with myopathy and functional studies have provided evidence that HSPB3 mutants could be associated with a gain of toxic function by inhibiting the formation of the HSPB2-HSPB3 complex and increasing the propensity to form nuclear aggregates [38].